River BioMedics paves the way to the future of cardiac drug discovery

Closer to the heart

We combine our cardiac biology knowhow with our expertise in bio-engineering and human induced pluripotent stem cells (hiPSC) to develop 3D cardiac in vitro models for the discovery and development of novel cardiac drugs.

Directly targeting the heart muscle

Human predictive 3D in-vitro models

Human induced pluripotent stem cell (hiPSC) technology 

High potential cardiac targets

Detailed clinically relevant read-outs

High-throughput in-house screening platforms

We strive for novelty

We mimic nature

We connect biology and engineering

We develop therapies

We value partnerships

Cardiovascular disease

the number one cause of death worldwide

We develop novel therapies for cardiac diseases by directly targeting the heart muscle

Meet the founders

We take on the challenge to bring cardiac drug development to the next level

Marcelo Ribeiro

Scientific and corporate development

Co-founder

Lisanne Blauw

Business and corporate development

Co-founder

Robert Passier

Scientific advisor

Co-founder

Recent News

Read More